Iraq vs Nepal: Treatment success rate for patients treated for MDR-TB
Iraq
76.0%
in 2022
Nepal
77.0%
in 2022
Iraq rank
64th
Nepal rank
61st
Treatment success rate for patients treated for MDR-TB over time
- Iraq
- Nepal
How they compare
Nepal currently reports 77.0% against 76.0% in Iraq, a difference of 1.0%.
The two have swapped places 4 times across 16 shared years of data; in 2007 it was Nepal ahead.
Iraq ranks 64th and Nepal ranks 61st of 163 countries.
Nepal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.0% | 69.7% | 37.7% | Nepal |
| 2010s | 62.4% | 72.0% | 9.6% | Nepal |
| 2020s | 75.0% | 76.3% | 1.3% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Iraq or Nepal?
- Nepal, at 77.0% against 76.0% in Iraq as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Iraq and Nepal?
- 1.0%, with Nepal ahead.
- How many years of comparable data are there for Iraq and Nepal?
- 16 years are reported by both, from 2007 to 2022.
- How do Iraq and Nepal rank globally for treatment success rate for patients treated for mdr-tb?
- Iraq ranks 64th and Nepal ranks 61st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.